SRTA
Strata Critical Medical, Inc.
4.70$
-2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 110.2% | 90.3% | 81.6% | 80.7% | 79.7% | 84.1% | 76.5% | 83.8% | 77.8% | 89.0% | 85.7% | 79.7% | 87.0% | 84.2% | 83.0% | 78.2% | 81.0% | 80.3% | 75.9% | 73.5% | 76.8% | 77.9% | 74.9% | 76.4% | 82.5% | 79.0% | 79.0% | 79.4% | |
| – | -10.2% | 9.7% | 18.4% | 19.3% | 20.3% | 15.9% | 23.5% | 16.2% | 22.2% | 11.0% | 14.3% | 20.3% | 13.0% | 15.8% | 17.0% | 21.8% | 19.0% | 19.7% | 24.1% | 26.5% | 23.2% | 22.1% | 25.1% | 23.6% | 17.5% | 21.0% | 21.0% | 20.6% | |
| – | 4.4% | 3.7% | 6.4% | 2.0% | 2.3% | 3.1% | 1.6% | 2.6% | 4.7% | 3.1% | 3.0% | 4.4% | 4.3% | 2.5% | 2.4% | 1.5% | 2.1% | 1.3% | 1.4% | 1.1% | 1.4% | 1.5% | 1.3% | 0.9% | 2.5% | 1.7% | 1.4% | 1.7% | |
| – | 57.6% | 43.5% | 45.4% | 23.0% | 42.1% | 50.7% | 75.7% | 50.1% | 58.6% | 52.5% | 34.1% | 34.6% | 54.0% | 35.9% | 30.2% | 27.0% | 86.9% | 33.4% | 37.0% | 27.3% | 34.9% | 31.9% | 28.4% | 33.1% | 25.2% | 23.2% | 12.2% | 22.5% | |
| – | 81.8% | 61.5% | 61.4% | 28.1% | 49.9% | 61.5% | 83.5% | 59.0% | 70.0% | 62.4% | 41.7% | 43.1% | 64.6% | 44.2% | 37.0% | 32.2% | 94.0% | 38.8% | 42.0% | 31.2% | 38.6% | 36.0% | 32.0% | 35.0% | 27.1% | 25.4% | 28.4% | 28.5% | |
| – | -92.0% | -51.9% | -42.9% | -8.8% | -29.7% | -45.6% | -60.0% | -42.8% | -47.9% | -51.4% | -27.3% | -22.8% | -51.6% | -28.3% | -20.0% | -10.4% | -75.1% | -19.2% | -17.9% | -4.7% | -15.4% | -14.0% | -7.0% | -11.4% | -9.6% | -4.4% | -7.5% | -8.0% | |
| – | – | – | – | – | 1.1% | – | 0.0% | 0.4% | 0.4% | 1.0% | 0.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -90.2% | -52.8% | -38.5% | -8.6% | -29.6% | -45.5% | -187.5% | 2.7% | -63.1% | -41.4% | 23.6% | -20.1% | -42.6% | -22.9% | -20.7% | 0.6% | -73.6% | -8.4% | -16.6% | -2.8% | -18.2% | -6.5% | -5.3% | -19.6% | -8.1% | 3.6% | -14.5% | -9.0% | |
| – | 4.0% | 2.4% | 0.0% | -0.3% | 1.1% | 9.1% | 0.0% | -0.4% | -17.9% | -1.0% | 0.7% | 0.1% | -2.2% | -0.4% | -0.6% | 0.2% | -2.2% | -0.2% | 0.1% | -0.2% | -0.2% | 0.0% | 0.0% | -131.6% | 5.2% | 0.4% | – | – | |
| – | 13.1% | -52.8% | -38.5% | -8.6% | -29.6% | -45.5% | -187.5% | 3.1% | -45.2% | -40.4% | 22.9% | -20.2% | -40.4% | -22.5% | -20.1% | 0.4% | -71.5% | -8.2% | -16.7% | -2.6% | -18.0% | -6.4% | -5.3% | 116.5% | -13.2% | 3.2% | -14.5% | 15.7% | |
| – | -89.4% | -49.8% | -39.1% | -7.2% | -27.9% | -44.2% | -187.5% | 5.6% | -61.8% | -36.1% | 26.8% | -17.1% | -42.4% | -20.4% | -17.7% | 3.2% | -69.8% | -5.3% | -14.3% | -1.1% | -15.4% | -3.3% | -2.7% | -16.1% | -0.8% | 1.7% | -2.8% | -3.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.